Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolina Ramirez

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Egastroenterology|April 25, 2025
Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: a global studyFrancisco Idalsoaga, Luis Antonio Diaz, Winston Dunn, et al.
Journal of Personalized Medicine|May 27, 2023
Personalized Interventional Surgery of the Lumbar Spine: A Perspective on Minimally Invasive and Neuroendoscopic Decompression for Spinal StenosisKai-Uwe Lewandrowski, Anthony Yeung, Morgan P Lorio, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2025
Comparison Between Dynamic Models for Predicting Response to Corticosteroids in Alcohol-Associated Hepatitis: A Global Cohort StudyFrancisco Idalsoaga, Luis Antonio Díaz, Leonardo Guizzetti, et al.
Hepatology Communications|March 25, 2025
Moderate alcohol-associated hepatitis: A real-world multicenter studyFrancisco Idalsoaga, Luis Antonio Díaz, Winston Dunn, et al.
Hepatology (Baltimore, Md.)|May 6, 2026
Exploring the interaction between metabolic dysfunction and alcohol-associated hepatitis: A global studyVania Cari, María Ignacia Perez, Ignacio Tellez, et al.
Hepatology (Baltimore, Md.)|April 12, 2024
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort studyWinston Dunn, Yanming Li, Ashwani K Singal, et al.
Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Paul Bastard, Adrian Gervais, et al.
Science Immunology|August 20, 2021
Autoantibodies neutralizing type I IFNs are present in <b>~</b>4% of uninfected individuals over 70 years old and account for <b>~</b>20% of COVID-19 deathsPaul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Egastroenterology|April 25, 2025
Pentoxifylline use in alcohol-associated hepatitis with acute kidney injury does not improve survival: a global studyFrancisco Idalsoaga, Luis Antonio Diaz, Winston Dunn, et al.
Journal of Personalized Medicine|May 27, 2023
Personalized Interventional Surgery of the Lumbar Spine: A Perspective on Minimally Invasive and Neuroendoscopic Decompression for Spinal StenosisKai-Uwe Lewandrowski, Anthony Yeung, Morgan P Lorio, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2025
Comparison Between Dynamic Models for Predicting Response to Corticosteroids in Alcohol-Associated Hepatitis: A Global Cohort StudyFrancisco Idalsoaga, Luis Antonio Díaz, Leonardo Guizzetti, et al.
Hepatology Communications|March 25, 2025
Moderate alcohol-associated hepatitis: A real-world multicenter studyFrancisco Idalsoaga, Luis Antonio Díaz, Winston Dunn, et al.
Hepatology (Baltimore, Md.)|May 6, 2026
Exploring the interaction between metabolic dysfunction and alcohol-associated hepatitis: A global studyVania Cari, María Ignacia Perez, Ignacio Tellez, et al.
Hepatology (Baltimore, Md.)|April 12, 2024
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort studyWinston Dunn, Yanming Li, Ashwani K Singal, et al.
Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Paul Bastard, Adrian Gervais, et al.
Science Immunology|August 20, 2021
Autoantibodies neutralizing type I IFNs are present in <b>~</b>4% of uninfected individuals over 70 years old and account for <b>~</b>20% of COVID-19 deathsPaul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Pageof 5